NVO
Novo Nordisk A/SANYSE / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
10
U.S. public peers
Grade Position
Above peers
vs peer average
NVO vs peer average
82/100
NVO vs. peer average (A vs. C)
Grade spread
A 1 · B 1 · C 6 · D 1 · F 1
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
AMGN is the first available peer comparator.
Relevant obesity-development comparator because MariTide frames medium-term competitive risk in the next wave of anti-obesity therapies rather than a current sales-share threat.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
NVO
Novo Nordisk A/S
AMGN
Amgen
Grade
A
C
Momentum
72
36
Value
63
64
Sentiment
71
47
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Mixed
Grade position vs AMGN
NVO / AMGN
Grade Position
Above peers
NVO vs. peer average (A vs. C)
82/100
Momentum
72
NVOValue
63
AMGNSentiment
71
NVORotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs NVO
AMGN is the first peer returned for this comparison set.